WALTHAM, Mass., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that the SPEAR Study Group has issued their consensus recommendation for a clinical study design to ...
MiNK Therapeutics, Inc., a clinical-stage biopharmaceutical company focusing on allogeneic invariant natural killer T (iNKT) cell therapies for cancer and immune diseases, announced it will present a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback